Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jubilant Biosys Ltd.

http://www.jubilantbiosys.com

Latest From Jubilant Biosys Ltd.

Fortress Biotech: A Drug Financing Experiment Expands

Fortress Biotech has established nine subsidiary companies since 2013, each financed differently and each focused on an area of unmet need. Fortress CEO and longtime life sciences investor Lindsay Rosenwald lays out his ambitious plans for the future.

Business Strategies Financing

Start-Up Quarterly Statistics, Q2 2016

A review of biopharma start-up dealmaking and financing from April through June 2016, based on data from Strategic Transactions.

Financing Deals

Sanofi Taps Jubilant Expertise For Metabolic Disorder Drug Discovery

India's biggest contract research firm Jubilant Life Sciences says it has joined forces with the German arm of France's biggest pharma firm Sanofi to discover new therapies for treating metabolic disorders.

BioPharmaceutical India

The Shake Up At Endo Pharma

Endo Pharma CEO Dave Holveck is diversifying the company from its core pain franchise into seemingly unrelated fields. Critics argue that he's neglecting its core strengths and acquiring mediocre assets, but he says such moves are necessary to address marketplace shifts.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
UsernamePublicRestriction

Register